Implant Sciences CE-marks brachytherapy seeds:
This article was originally published in Clinica
Executive Summary
Implant Sciences has CE-marked for sale in Europe its I-Plant radioactive iodine-125 seeds for treating prostate cancer. The Wakefield, Massachusetts firm has already gained approval to sell the product in the US (see Clinica No 863, p 18).